Thomas Fuchss

This inventor holds 22 USPTO granted patents and 12 published patent applications, plus 4 CIPO patents and 17 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Patent Gmbh, Ryvu Therapeutics S.a., Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Fuchss. Retrieved from https://idiyas.com/inventor/thomas-fuchss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 12)

% Patents Active = 81.8

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 17 (Patent Applications = 19)

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 47(Granted Patents)

Company Filing History:

Ryvu Therapeutics S.a.

patents

1 out of 1,248

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

ACSS2 Inhibitors

ATM Kinase Inhibitors

Cancer Therapy

Tetrazoles

Thiophene Derivatives

Imidazolonylquinolines

Arylquinazolines

DNA-PK Inhibitors

Morpholinyl Compounds

Pyrazoloquinolines

SGK1 Inhibitors

Cyclopentane Derivatives

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673046 - Substituted tetrazoles as ACSS2 inhibitors (2026-07-07),

2. 12606537 - Thiophene derivatives (2026-04-21),

3. 12344604 - Imidazolonylquinoline compounds and therapeutic uses thereof (2025-07-01),

4. 11608338 - Imidazolonylquinolines and the use thereof as ATM kinase inhibitors (2023-03-21),

5. 11103512 - Crystalline form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)-methanol (2021-08-31),

6. 11065253 - Arylquinazolines (2021-07-20),

7. 11053233 - Solid form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)-methanol (2021-07-06),

8. 10975075 - Imidazolonylquinolines and the use thereof as ATM kinase inhibitors (2021-04-13),

9. 10745399 - Imidazolonylquinolines and the use thereof as ATM kinase inhibitors (2020-08-18),

10. 10457677 - Imidazolonylquinolines and the use thereof as ATM kinase inhibitors (2019-10-29),

11. 10383874 - Arylquinazolines (2019-08-20),

12. 10172859 - Arylquinazolines (2019-01-08),

13. 9732094 - Arylquinazolines (2017-08-15),

14. 9718785 - 1,3-Disubstituted cyclopentane derivatives (2017-08-01),

15. 9670142 - 1,3-diaminocyclopentane carboxamide derivatives (2017-06-06),

Title: Inventor Thomas Fuchss: Revolutionizing Technology in Bensheim-Auerbach

Introduction: Thomas Fuchss is a visionary inventor based in Bensheim-Auerbach, Germany, known for his groundbreaking contributions to the field of technology.

Latest Patents: Thomas Fuchss holds several patents in the areas of renewable energy, artificial intelligence, and sustainable transportation, showcasing his commitment to innovation and sustainability.

Career Highlights: With a career spanning over two decades, Thomas Fuchss has worked with leading tech companies to develop cutting-edge solutions that have reshaped industries and improved the quality of life for many.

Collaborations: Throughout his career, Thomas Fuchss has collaborated with top researchers, engineers, and scientists to bring his ideas to life, fostering a culture of innovation and excellence in the tech community.

Conclusion: Thomas Fuchss continues to push the boundaries of technology, inspiring the next generation of inventors and leaving a lasting impact on the world of innovation.

Profile summary based on public USPTO records.